These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 19581260)

  • 41. Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting.
    Snelling TL; Schultz R; Graham J; Roseby R; Barnes GL; Andrews RM; Carapetis JR
    Clin Infect Dis; 2009 Aug; 49(3):428-31. PubMed ID: 19566443
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The evolving epidemiology of rotavirus gastroenteritis in central Portugal with modest vaccine coverage.
    Rodrigues F; Iturriza-Gómara M; Marlow R; Gray J; Nawaz S; Januário L; Finn A
    J Clin Virol; 2013 Feb; 56(2):129-34. PubMed ID: 23238239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.
    Hull JJ; Teel EN; Kerin TK; Freeman MM; Esona MD; Gentsch JR; Cortese MM; Parashar UD; Glass RI; Bowen MD;
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S42-7. PubMed ID: 21183839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Real-world impact of rotavirus vaccination.
    Patel MM; Steele D; Gentsch JR; Wecker J; Glass RI; Parashar UD
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S1-5. PubMed ID: 21183833
    [No Abstract]   [Full Text] [Related]  

  • 45. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
    Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
    Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children.
    Anderson EJ; Rupp A; Shulman ST; Wang D; Zheng X; Noskin GA
    Pediatrics; 2011 Feb; 127(2):e264-70. PubMed ID: 21262887
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the Likely Impact of a Rotavirus Vaccination Program in England: The Contribution of Syndromic Surveillance.
    Bawa Z; Elliot AJ; Morbey RA; Ladhani S; Cunliffe NA; O'Brien SJ; Regan M; Smith GE
    Clin Infect Dis; 2015 Jul; 61(1):77-85. PubMed ID: 25828997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.
    Block SL; Vesikari T; Goveia MG; Rivers SB; Adeyi BA; Dallas MJ; Bauder J; Boslego JW; Heaton PM;
    Pediatrics; 2007 Jan; 119(1):11-8. PubMed ID: 17200266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium.
    Zeller M; Rahman M; Heylen E; De Coster S; De Vos S; Arijs I; Novo L; Verstappen N; Van Ranst M; Matthijnssens J
    Vaccine; 2010 Nov; 28(47):7507-13. PubMed ID: 20851085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015.
    Curns AT; Coffin F; Glasser JW; Glass RI; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S49-56. PubMed ID: 19817614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data.
    Iturriza-Gómara M; Dallman T; Bányai K; Böttiger B; Buesa J; Diedrich S; Fiore L; Johansen K; Korsun N; Kroneman A; Lappalainen M; László B; Maunula L; Matthinjnssens J; Midgley S; Mladenova Z; Poljsak-Prijatelj M; Pothier P; Ruggeri FM; Sanchez-Fauquier A; Schreier E; Steyer A; Sidaraviciute I; Tran AN; Usonis V; Van Ranst M; de Rougemont A; Gray J
    J Infect Dis; 2009 Nov; 200 Suppl 1():S215-21. PubMed ID: 19821712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007.
    ;
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):398-401. PubMed ID: 18418345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [500,000 cases per year in Germany. There is now a vaccine for control of rotavirus infection].
    MMW Fortschr Med; 2006 Oct; 148(41):6-7. PubMed ID: 17190246
    [No Abstract]   [Full Text] [Related]  

  • 54. Temporal and geographic trends of rotavirus activity in the United States, 1997-2004.
    Turcios RM; Curns AT; Holman RC; Pandya-Smith I; LaMonte A; Bresee JS; Glass RI;
    Pediatr Infect Dis J; 2006 May; 25(5):451-4. PubMed ID: 16645512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
    Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
    Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rotavirus vaccination coverage among infants aged 5 months - immunization information system sentinel sites, United States, June 2006-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):521-4. PubMed ID: 20448529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa.
    Groome MJ; Zell ER; Solomon F; Nzenze S; Parashar UD; Izu A; Madhi SA
    Clin Infect Dis; 2016 May; 62 Suppl 2():S188-95. PubMed ID: 27059355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sustained decrease in laboratory detection of rotavirus after implementation of routine vaccination—United States, 2000-2014.
    Aliabadi N; Tate JE; Haynes AK; Parashar UD;
    MMWR Morb Mortal Wkly Rep; 2015 Apr; 64(13):337-42. PubMed ID: 25856253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease.
    Harris JP; Jit M; Cooper D; Edmunds WJ
    Vaccine; 2007 May; 25(20):3962-70. PubMed ID: 17395343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.